Strategic Services Growth Zymo Services launch signals a move toward integrated, partner focused offerings. This creates opportunities to engage pharma, biotech and academic customers with end to end workflows, combining sample prep, automation and expert support under a single value proposition. Sales messaging can emphasize co development options, bundled reagents and service contracts to deepen customer relationships.

Women’s Health Opportunity The collaboration with Stori to bring a cell free DNA early pregnancy test highlights strength in women's health and cfDNA workflows. Target opportunities include OB/GYN clinics, fertility centers and diagnostics labs, offering accompanying purification kits and analysis tools to accelerate development and scale production.

NGS Automation New libraries and automation capabilities with Endura Tn5 and MultiOmiX position Zymo as a go to supplier for NGS core facilities and CROs. Sell end to end sequencing workflows, including library prep reagents, automated platforms and technical support, with potential for volume discounts and enterprise partnerships.

Environmental Health Active involvement in wastewater microbiology suggests a growing addressable market in environmental surveillance. Potential customers include municipal labs, water utilities and universities seeking robust sample prep and sequencing ready workflows for surveillance, projects, and outbreak monitoring. Propose environmental workflow bundles and ongoing support arrangements.

Growth Readiness Strong research heritage, publication footprint and a mid market scale offer confidence for channel expansion and regional growth. Opportunities include international distributors, regional sales teams, and training services to accelerate adoption of DNA/RNA purification and epigenetics tools across labs, clinics and biotech companies.